Taking Stock: Manley on Markets, Frost on Biotech

GUESTS: John Leo Manley Chief Equity Strategist Wells Fargo Funds Mgmt Discussing the impact of a correction in the market, as well as investment ideas

Phillip Frost Chairman/CEO OPKO Health Inc (OPK) Discussing Phase III data for a Kidney disease drug Rayaldee

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.